These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
748 related articles for article (PubMed ID: 32312637)
1. Differential methylation landscape of pancreatic ductal adenocarcinoma and its precancerous lesions. Bararia A; Dey S; Gulati S; Ghatak S; Ghosh S; Banerjee S; Sikdar N Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):205-217. PubMed ID: 32312637 [TBL] [Abstract][Full Text] [Related]
2. Molecular signatures of pancreatic cancer. Hong SM; Park JY; Hruban RH; Goggins M Arch Pathol Lab Med; 2011 Jun; 135(6):716-27. PubMed ID: 21631264 [TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas. Sato N; Ueki T; Fukushima N; Iacobuzio-Donahue CA; Yeo CJ; Cameron JL; Hruban RH; Goggins M Gastroenterology; 2002 Jul; 123(1):365-72. PubMed ID: 12105864 [TBL] [Abstract][Full Text] [Related]
4. Can we predict the progression of premalignant pancreatic cystic tumors to ductal adenocarcinoma? Chidambaram S; Kawka M; Gall TM; Cunningham D; Jiao LR Future Oncol; 2022 Jul; 18(23):2605-2612. PubMed ID: 35730473 [TBL] [Abstract][Full Text] [Related]
5. The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis. Hanoun N; Delpu Y; Suriawinata AA; Bournet B; Bureau C; Selves J; Tsongalis GJ; Dufresne M; Buscail L; Cordelier P; Torrisani J Clin Chem; 2010 Jul; 56(7):1107-18. PubMed ID: 20431052 [TBL] [Abstract][Full Text] [Related]
6. Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development. Dutruel C; Bergmann F; Rooman I; Zucknick M; Weichenhan D; Geiselhart L; Kaffenberger T; Rachakonda PS; Bauer A; Giese N; Hong C; Xie H; Costello JF; Hoheisel J; Kumar R; Rehli M; Schirmacher P; Werner J; Plass C; Popanda O; Schmezer P Oncogene; 2014 Jun; 33(26):3401-10. PubMed ID: 23912455 [TBL] [Abstract][Full Text] [Related]
7. Combined Analysis of the Aberrant Epigenetic Alteration of Pancreatic Ductal Adenocarcinoma. Xu R; Xu Q; Huang G; Yin X; Zhu J; Peng Y; Song J Biomed Res Int; 2019; 2019():9379864. PubMed ID: 31956659 [TBL] [Abstract][Full Text] [Related]
8. Dipeptidyl peptidase like 6 promoter methylation is a potential prognostic biomarker for pancreatic ductal adenocarcinoma. Zhao X; Cao D; Ren Z; Liu Z; Lv S; Zhu J; Li L; Lang R; He Q Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32701143 [TBL] [Abstract][Full Text] [Related]
9. Acvr1b Loss Increases Formation of Pancreatic Precancerous Lesions From Acinar and Ductal Cells of Origin. Saeki K; Wood IS; Wang WCK; Patil S; Sun Y; Schaeffer DF; Su GH; Kopp JL Cell Mol Gastroenterol Hepatol; 2024; 18(5):101387. PubMed ID: 39111635 [TBL] [Abstract][Full Text] [Related]
10. Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas. Hong SM; Kelly D; Griffith M; Omura N; Li A; Li CP; Hruban RH; Goggins M Mod Pathol; 2008 Dec; 21(12):1499-507. PubMed ID: 18820670 [TBL] [Abstract][Full Text] [Related]
11. Cell-Free DNA Methylation: The New Frontiers of Pancreatic Cancer Biomarkers' Discovery. Brancaccio M; Natale F; Falco G; Angrisano T Genes (Basel); 2019 Dec; 11(1):. PubMed ID: 31877923 [TBL] [Abstract][Full Text] [Related]
12. Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Nones K; Waddell N; Song S; Patch AM; Miller D; Johns A; Wu J; Kassahn KS; Wood D; Bailey P; Fink L; Manning S; Christ AN; Nourse C; Kazakoff S; Taylor D; Leonard C; Chang DK; Jones MD; Thomas M; Watson C; Pinese M; Cowley M; Rooman I; Pajic M; ; Butturini G; Malpaga A; Corbo V; Crippa S; Falconi M; Zamboni G; Castelli P; Lawlor RT; Gill AJ; Scarpa A; Pearson JV; Biankin AV; Grimmond SM Int J Cancer; 2014 Sep; 135(5):1110-8. PubMed ID: 24500968 [TBL] [Abstract][Full Text] [Related]
13. High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma. Curia MC; Fantini F; Lattanzio R; Tavano F; Di Mola F; Piantelli M; Battista P; Di Sebastiano P; Cama A BMC Cancer; 2019 May; 19(1):452. PubMed ID: 31088413 [TBL] [Abstract][Full Text] [Related]
14. SST gene hypermethylation acts as a pan-cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood-based diagnosis. Manoochehri M; Wu Y; Giese NA; Strobel O; Kutschmann S; Haller F; Hoheisel JD; Moskalev EA; Hackert T; Bauer AS Mol Oncol; 2020 Jun; 14(6):1252-1267. PubMed ID: 32243066 [TBL] [Abstract][Full Text] [Related]
16. Annexin A10 is a candidate marker associated with the progression of pancreatic precursor lesions to adenocarcinoma. Zhu J; Wu J; Pei X; Tan Z; Shi J; Lubman DM PLoS One; 2017; 12(4):e0175039. PubMed ID: 28369074 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic alterations in intraductal papillary mucinous neoplasms of the pancreas. Sato N; Goggins M J Hepatobiliary Pancreat Surg; 2006; 13(4):280-5. PubMed ID: 16858538 [TBL] [Abstract][Full Text] [Related]
18. Pathology of Pancreatic Cancer Precursor Lesions. Noë M; Brosens LA Surg Pathol Clin; 2016 Dec; 9(4):561-580. PubMed ID: 27926360 [TBL] [Abstract][Full Text] [Related]
19. Clinical significance of promoter methylation status of tumor suppressor genes in circulating DNA of pancreatic cancer patients. Singh N; Rashid S; Rashid S; Dash NR; Gupta S; Saraya A J Cancer Res Clin Oncol; 2020 Apr; 146(4):897-907. PubMed ID: 32146565 [TBL] [Abstract][Full Text] [Related]
20. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues. Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]